# OnCo record targeted-alpha-therapy (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/targeted-alpha-therapy/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "targeted-alpha-therapy" ;
  schema:name "Targeted alpha therapy"@en ;
  schema:description "Like radioligand therapy but with alpha particles: far more destructive over a much shorter range, so single cells can be killed with less collateral damage."@en ;
  schema:url <https://onco.cc/technologies/targeted-alpha-therapy/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Targeted_alpha-particle_therapy> ;
  owl:sameAs <http://www.wikidata.org/entity/Q23021051> ;
  schema:citation <https://en.wikipedia.org/wiki/Targeted_alpha-particle_therapy> ;
  onco:status "phase-3" ;
  onco:tag "frontier" ;
  onco:related <https://onco.cc/technologies/astatine-211-alpha-therapy/> ;
  onco:sections <https://onco.cc/fronts/radiopharma/> ;
  onco:technologies <https://onco.cc/technologies/radioligand-therapy/> ;
  onco:targets <https://onco.cc/targets/psma/>, <https://onco.cc/targets/sstr2/>, <https://onco.cc/targets/fap/> ;
  onco:companies <https://onco.cc/companies/terrapower-isotopes/>, <https://onco.cc/companies/orano-med/>, <https://onco.cc/companies/itm/>, <https://onco.cc/companies/rayzebio/>, <https://onco.cc/companies/fusion-pharma/>, <https://onco.cc/companies/abdera-therapeutics/>, <https://onco.cc/companies/actinium-pharmaceuticals/>, <https://onco.cc/companies/alpha-9-oncology/>, <https://onco.cc/companies/ariceum-therapeutics/>, <https://onco.cc/companies/artbio/>, <https://onco.cc/companies/convergent-therapeutics/>, <https://onco.cc/companies/ratio-therapeutics/> ;
  onco:dependsOn <https://onco.cc/technologies/therapy-isotope-supply-chain/>, <https://onco.cc/technologies/radiopharmacy-network/>, <https://onco.cc/technologies/radioligand-dosimetry/> .